Alivus Life Sciences Limited (NSE:ALIVUS)
India · Delayed Price · Currency is INR 1,446.00
-8.90 (-0.61%)
Nov 12, 2026, 3:30 PM IST
Alivus Life Sciences Market Cap
Alivus Life Sciences has a market cap or net worth of 177.53 billion as of November 12, 2026. It is the 6,793rd most valuable company in the world and the 395th biggest in India. Its market cap has increased by 58.39% in one year.
Market Cap
177.53B
Enterprise Value
167.94B
Revenue
26.84B
Global Rank
Country Rank
#395 India
PE Ratio
26.57
ChartMarket Cap Chart
Since August 6, 2021, Alivus Life Sciences's market cap has increased from 91.71B to 177.53B, an increase of 93.57%. That is a compound annual growth rate of 13.35%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 12, 2026 | 177.53B | 57.87% |
| Dec 31, 2025 | 112.45B | -6.68% |
| Dec 31, 2024 | 120.50B | 49.68% |
| Dec 29, 2023 | 80.51B | 56.38% |
| Dec 30, 2022 | 51.48B | -33.42% |
| Dec 31, 2021 | 77.32B | -15.69% |
| Aug 6, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Ajanta Pharma | 414.79B |
| Wockhardt | 329.86B |
| Piramal Pharma | 326.07B |
| Alembic Pharmaceuticals | 202.36B |
| Cohance Lifesciences | 177.45B |
| Eris Lifesciences | 176.78B |
| NATCO Pharma | 158.88B |
| Sudeep Pharma | 136.22B |